1. Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment. Issue 4 (5th July 2022) Authors: Toussi, Sima S.; Neutel, Joel Michael; Navarro, Jesus; Preston, Richard Alfred; Shi, Haihong; Kavetska, Olga; LaBadie, Robert R.; Binks, Michael; Chan, Phylinda L.S.; Demers, Neil; Corrigan, Brian; Damle, Bharat Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗